New drugs of 2001.
OBJECTIVE
To provide information regarding the most important properties of the new therapeutic agents marketed in 2001.


METHODS
Published studies, drug information reference sources, and product labeling.


RESULTS
In 2001, 26 new therapeutic agents were marketed. The indications and information on dosage and administration for the new agents are reviewed, as are the most important pharmacokinetic properties, adverse events, drug interactions, and other precautions. Practical considerations for the use of the new agents are also discussed. Where possible, the properties of the new drugs are compared with those of older drugs marketed for the same indications.


CONCLUSIONS
A number of the new therapeutic agents marketed in 2001 have important advantages over older medications. An understanding of the properties of these agents is important if the pharmacist is to effectively counsel patients about their use and to serve as a valuable source of information for other health professionals regarding these drugs.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA 19104-4495, USA.
D000818:Animals; D017277:Drug Approval; D004358:Drug Therapy; D006801:Humans; D004364:Pharmaceutical Preparations; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations